First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Trading Down 0% – Here’s Why

Shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXHGet Free Report) fell 0% during trading on Monday . The company traded as low as $27.03 and last traded at $27.09. 2,170 shares traded hands during trading, a decline of 59% from the average session volume of 5,314 shares. The stock had previously closed at $27.10.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

The stock has a market cap of $16.26 million, a price-to-earnings ratio of 15.98 and a beta of 0.70. The company’s fifty day simple moving average is $28.62 and its two-hundred day simple moving average is $28.09.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Thursday, September 26th were given a $0.1218 dividend. The ex-dividend date was Thursday, September 26th. This represents a $0.49 annualized dividend and a yield of 1.80%.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in First Trust Nasdaq Pharmaceuticals ETF stock. International Assets Investment Management LLC purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXHFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,662 shares of the company’s stock, valued at approximately $73,000. International Assets Investment Management LLC owned about 0.41% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

First Trust Nasdaq Pharmaceuticals ETF Company Profile

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

See Also

Receive News & Ratings for First Trust Nasdaq Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.